• Sun Pharma reported 13% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter ended June (Q1FY23). On a year-on-year (YoY) basis, it witnessed a growth of 9%.
  • Its expenses for the quarter were up by 10% QoQ and 14% YoY.
  • The net profit increased by 43% on a YoY basis..
  • The earnings per share (EPS) of Sun Pharma stood at 8.6 during Q1FY23..

Sun Pharma’s Financial Statements for Q1FY23:

(Rs, crores) Q1FY22 Q4FY22 Q1FY23 QoQ (%) YoY (%)
Total Income 9,871 9,560 10,764 13% 9%
Total Expenses 7,436 7,700 8,479 10% 14%
Profit before tax 1,804 -2,076 2,285 - 27%
Tax 396 147 189 29% -52%
Profit after tax 1,444 -2,277 2,061 - 43%
Earnings per share 6.0 - 8.6    

Data Source: BSE, Company announcements

Want to keep a tab on Indian listed companies? Open an account and get daily stock research updates from Kotak Securities.

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results